Increased HCMV seroprevalence in patients with hepatocellular carcinoma

Table 3 Factors associated with HCC and with HCMV seropositivity.

Unimodal analysis
HCMV associated factors
	HCC	Cirrhosis	HCV	HBV	HIV	Male gender	Exposition to hepatotropic viruses
p	*0.023*	0.24	0.23	0.57	0.83	0.09	0.21
HCC associated factors
	HCMV IgG+	Cirrhosis	HCV	HBV	HIV	Male	Exposition to hepat. viruses
p	*0.023*	0	*0.046*	0.55	0.26	0.21	0.08
Multimodal analysis
HCMV associated factors
	Odds Ratio			CI95%	p
HCC	3.45			1.34-8.93	*0.010*
Cirrhosis	0.71			0.31-1.62	0.418
Age > 65 years	0.59			0.31-1.14	0.119
Exposition to hepatotropic viruses	1.35			0.62-2.94	0.448
Male gender	0.43			0.15-1.24	0.118
HCC associated factors
IgG HCMV+	2.76			1.30-5.86	*0.008*
Age > 65 years	1.48			0.73-2.98	0.278
Exposition to hepatotropic viruses	2.07			0.96-4.45	0.064
Male gender	2.80			0.84-9.30	0.093

ISSN: 1743-422X